EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer

Jessica E Hawley, Aleksandar Z Obradovic, Matthew C Dallos, Emerson A Lim, Karie Runcie, Casey R Ager, James McKiernan, Christopher B Anderson, Guarionex J Decastro, Joshua Weintraub, Renu Virk, Israel Lowy und 9 weitere

Cancer Cell · 2023

DOI: 10.1016/j.ccell.2023.10.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2023. Verfasst von Jessica E Hawley und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantMaleHumansAndrogen AntagonistsAndrogensImmunotherapyCastrationTumor Microenvironment

Stichwörter der Autor:innen

ADTanti-PD-1 therapyclinical translational scienceclinical trialhormone-sensitiveimmunotherapymetastatic prostate cancersingle cell RNA sequencingtumor microenvironment

Substanzen

Androgen AntagonistsAndrogens

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
  • Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, USA; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.
  • Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.
  • Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Urology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New…
  • Department of Interventional Radiology, Columbia University Irving Medical Center, New York, NY, USA.
  • Department of Pathology, Columbia University Irving Medical Center, New York, NY, USA.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Hawley, J. E., Obradovic, A. Z., Dallos, M. C., Lim, E. A., Runcie, K., Ager, C. R., McKiernan, J., Anderson, C. B., Decastro, G. J., Weintraub, J., Virk, R., Lowy, I., Hu, J., Chaimowitz, M. G., Guo, X. V., Zhang, Y., Haffner, M. C., Worley, J., Stein, M. N., …, & Drake, C. G. (2023). Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2023.10.006

Vancouver

Hawley JE, Obradovic AZ, Dallos MC, Lim EA, Runcie K, Ager CR, et al. Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. Cancer Cell. 2023. doi:10.1016/j.ccell.2023.10.006

BibTeX
@article{Hawley2023,
  author = {Hawley, Jessica E and Obradovic, Aleksandar Z and Dallos, Matthew C and Lim, Emerson A and Runcie, Karie and Ager, Casey R and McKiernan, James and Anderson, Christopher B and Decastro, Guarionex J and Weintraub, Joshua and Virk, Renu and Lowy, Israel and Hu, Jianhua and Chaimowitz, Matthew G and Guo, Xinzheng V and Zhang, Ya and Haffner, Michael C and Worley, Jeremy and Stein, Mark N and Califano, Andrea and Drake, Charles G},
  title = {Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer},
  journal = {Cancer Cell},
  year = {2023},
  doi = {10.1016/j.ccell.2023.10.006}
}
Kostenlos starten →